CHATSWORTH, Calif., Oct. 18, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Chairman, President and Chief Executive Officer, Cesar M. Garcia, will present an overview of the Company at the Oppenheimer 21st Annual Healthcare Conference on Wednesday, November 3, 2010, at 1:35 p.m. Eastern time at the Waldorf-Astoria Hotel in New York City.
